Prot# Aramchol-018: A Phase 3/4, Multinational, Multicenter, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects with Nonalcoholic Steatohepatitis (NASH)

Project: Research project

Project Details

StatusActive
Effective start/end date12/23/1912/23/23

Funding

  • Covance Inc. (Prot# Aramchol-018)
  • Galmed Research and Development Ltd. (Prot# Aramchol-018)